Ligand Pharmaceuticals (LGND) Tax Rate (2010 - 2026)
Ligand Pharmaceuticals (LGND) posted Tax Rate of 44.99% for Q1 2026, up 112.95% sequentially from 21.13% in Q4 2025, and up 2959.0% YoY from 1.47% in Q1 2025.
Ligand Pharmaceuticals (LGND) Tax Rate (2010 - 2026) Analysis & Trends
Ligand Pharmaceuticals has reported Tax Rate for 17 years, with the latest figure at 44.99% in Q1 2026.
- Quarterly Tax Rate rose 2959.0% year-over-year to 44.99% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 16.94% (down 74.0% YoY) and the FY2025 annual result came in at 21.71%, down 23842.0% from the prior year.
- Tax Rate rose to 44.99% in Q1 2026 per LGND's latest filing, from 21.13% in the prior quarter.
- Over five years, Tax Rate peaked at 160.21% in Q4 2022 and troughed at 45.47% in Q2 2022.
- A 5-year average of 21.24% and a median of 20.69% in 2024 frame the typical range for Tax Rate.
- The sharpest annual moves came in 2022 and 2023: Tax Rate surged 17273 bps in 2022, then sank 16659 bps in 2023.
- Over 5 years, Tax Rate stood at 160.21% in 2022, then plunged by 104 bps to 6.38% in 2023, then soared by 424 bps to 20.69% in 2024, then advanced by 2 bps to 21.13% in 2025, then soared by 113 bps to 44.99% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 44.99%, 21.13%, and 16.91% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Ligand Pharmaceuticals | 5.87 Bn | 4.51 Bn | 60.48 Mn | 24.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.56% |
| Jun 30, 2026 | 24.56% |
| Jun 30, 2026 | 24.56% |
| Mar 31, 2026 | 44.99% |
| Mar 31, 2026 | 44.99% |
| Mar 31, 2026 | 44.99% |
| Dec 31, 2025 | 21.13% |
| Dec 31, 2025 | 21.13% |
| Dec 31, 2025 | 21.13% |
| Sep 30, 2025 | 16.91% |
| Sep 30, 2025 | 16.91% |
| Sep 30, 2025 | 16.91% |
| Jun 30, 2025 | 56.81% |
| Jun 30, 2025 | 56.81% |
| Jun 30, 2025 | 56.81% |
| Mar 31, 2025 | 15.40% |
| Mar 31, 2025 | 15.40% |
| Mar 31, 2025 | 15.40% |
| Dec 31, 2024 | 20.69% |
| Dec 31, 2024 | 20.69% |